Abstract
Verbal fluency tests (VFT) are often used to assess executive functioning in Parkinson’s disease (PD). Various cognitive functions may, however, impair performance on VFT. Furthermore, since PD is a progressive neurodegenerative disease, it is also not clear whether deficits on VFT reflect impairments in the same cognitive functions throughout the different disease stages. This study will investigate what is measured with VFT in PD, in particular at different disease stages. Eighty-eight PD patients and 65 healthy participants, matched for age, gender, and education, were included. All were assessed with semantic and phonemic VFT and tests assessing executive functions, memory, and psychomotor speed. Mild and moderate PD patients did not differ in the number of words generated on both VFT. However, mild and moderate PD patients differed significantly with regard to the size of the largest cluster and the number of intra-dimensional shifts on phonemic VFT. Furthermore, at the mild disease stages, psychomotor speed predicted the performance on both VFT; whereas at the moderate stages of the disease, cognitive flexibility and psychomotor speed predicted the performance on both VFT. In conclusion, different cognitive functions underlie the performances of PD patients at different stages of the disease on semantic and phonemic VFT. Impairments in VFT, therefore, do not necessarily represent a specific deficit of executive functioning in patients with PD but should rather be interpreted in the context of disease severity and dysfunctions in other domains of cognition.
Similar content being viewed by others
References
Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75(12):1062–1069. doi:10.1212/WNL.0b013e3181f39d0e
Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, Dekosky ST (2006) Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and Parkinsonian dementia. J Neurol 253(2):242–247. doi:10.1007/s00415-005-0971-0
Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical Excellence (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245. doi:10.1016/S1474-4422(06)70373-8
Cools R (2006) Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson’s disease. Neurosci Biobehav Rev 30(1):1–23
Cools R, Barker RA, Sahakian BJ, Robbins TW (2001) Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cerebral Cortex 11(12):1136–1143
Esselink RA, de Bie RM, de Haan RJ (2004) Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 62(2):201–207
Flowers KA, Robertson C (1985) The effect of Parkinson’s disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry 48(6):517–529
Flowers KA, Robertson C, Sheridan MR (1995) Some characteristics of word fluency in Parkinson’s disease. J Neurolinguist 9:33–46
Hammes JGW (1978) De stroop-kleur-woord test handleiding. Pearson, Amsterdam
Henry JD, Crawford JR (2004) Verbal fluency deficits in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc 10(4):608–622. doi:10.1017/S1355617704104141
Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, Heiss WD (2005) Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65(11):1716–1722. doi:10.1212/01.wnl.0000191154.78131.f6
Koerts J, Van Beilen M, Tucha O, Leenders KL, Brouwer WH (2011) Executive functioning in daily life in Parkinson’s disease: initiative, planning and multi-task performance. PLoS One 6(12):e29254. doi:10.1371/journal.pone.0029254
Lange KW, Tucha O, Alders GL, Preier M, Csoti I, Merz B, Naumann M (2003) Differentiation of Parkinsonian syndromes according to differences in executive functions. J Neural Transm 110(9):983–995. doi:10.1007/s00702-003-0011-0
Leary MR, Altmaier EM (1980) Type I error in counseling research: a plea for multivariate analyses. J Counsel Psychol 27(6):611–615
Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW (2000) The validity of the Hamilton and Montgomery–Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson’s disease. Int J Geriatric Psychiatry 15(7):644–649
McDowd J, Hoffman L, Rozek E, Lyons KE, Pahwa R, Burns J, Kemper S (2011) Understanding verbal fluency in healthy aging, Alzheimer’s disease, and Parkinson’s disease. Neuropsychology 25(2):210–225. doi:10.1037/a0021531
Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65(8):1239–1245
Muslimovic D, Schmand B, Speelman JD, de Haan RJ (2007) Course of cognitive decline in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc 13(6):920–932. doi:10.1017/S1355617707071160
Muslimovic D, Post B, Speelman JD, De Haan RJ, Schmand B (2009) Cognitive decline in Parkinson’s disease: a prospective longitudinal study. J Int Neuropsychol Soc 15(3):426–437. doi:10.1017/S1355617709090614
Raskin SA, Sliwinski M, Borod JC (1992) Clustering strategies on tasks of verbal fluency in Parkinson’s disease. Neuropsychologia 30(1):95–99
Reitan RM (1958) Validity of the trail making test as an indicator of organic braindamage. Percept Mot Skills 8:271–276
Saan RJ, Deelman BG (1986) De 15-woorden test A (manual). Afdeling neuropsychologie UMCG (internal publication), Groningen
Schmand B, Groenink SC, van den Dungen M (2008) Letter fluency: psychometric properties and Dutch normative data. Tijdschr Gerontol Geriatr 39(2):64–76
Troyer AK (2000) Normative data for clustering and switching on verbal fluency tasks. J Clin Exp Neuropsychol 22(3):370–378. doi:FT370
Troyer AK, Moscovitch M, Winocur G (1997) Clustering and switching as two components of verbal fluency: evidence from younger and older healthy adults. Neuropsychology 11(1):138–146
Troyer AK, Moscovitch M, Winocur G, Leach L, Freedman M (1998) Clustering and switching on verbal fluency tests in Alzheimer’s and Parkinson’s disease. J Int Neuropsychol Soc 4(2):137–143
Unsworth N, Spillers GJ, Brewer GA (2011) Variation in verbal fluency: a latent variable analysis of clustering, switching, and overall performance. Q J Exp Psychol 64(3):447–466. doi:10(1080/17470218).2010.505292
van Beilen M, Pijnenborg M, van Zomeren EH, van den Bosch RJ, Withaar FK, Bouma A (2004) What is measured by verbal fluency tests in schizophrenia? Schizophr Res 69(2–3):267–276
Wechsler D (1987) Wechsler memory scale—revised. The Psychological Corporation, San Antonio
Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain 130(1460–2156):1787–1798
Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Barker RA (2009) The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132(Pt 11):2958–2969. doi:10.1093/brain/awp245
Author information
Authors and Affiliations
Corresponding author
Additional information
J. Koerts and H. A. Meijer contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Koerts, J., Meijer, H.A., Colman, K.S.F. et al. What is measured with verbal fluency tests in Parkinson’s disease patients at different stages of the disease?. J Neural Transm 120, 403–411 (2013). https://doi.org/10.1007/s00702-012-0885-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-012-0885-9